Bevacizumab and temozolomide plus radiation regimen for glioblastoma multiforme

Matthew R. Rutledge, James Waddell, Dominic A. Solimando

Research output: Contribution to journalArticle

Abstract

The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.

Original languageEnglish (US)
Pages (from-to)672-677
Number of pages6
JournalHospital Pharmacy
Volume50
Issue number8
DOIs
StatePublished - Jan 1 2015

Fingerprint

temozolomide
Poisons
Glioblastoma
Pharmacists
Antineoplastic Agents
Radiation
Drug Therapy
Chemotherapy
Neoplasms
Therapeutics
Bevacizumab

All Science Journal Classification (ASJC) codes

  • Pharmacy
  • Pharmacology
  • Pharmacology (medical)

Cite this

Bevacizumab and temozolomide plus radiation regimen for glioblastoma multiforme. / Rutledge, Matthew R.; Waddell, James; Solimando, Dominic A.

In: Hospital Pharmacy, Vol. 50, No. 8, 01.01.2015, p. 672-677.

Research output: Contribution to journalArticle

Rutledge, Matthew R. ; Waddell, James ; Solimando, Dominic A. / Bevacizumab and temozolomide plus radiation regimen for glioblastoma multiforme. In: Hospital Pharmacy. 2015 ; Vol. 50, No. 8. pp. 672-677.
@article{5cc4dbef4fb34f52be109f6a0c0d1146,
title = "Bevacizumab and temozolomide plus radiation regimen for glioblastoma multiforme",
abstract = "The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.",
author = "Rutledge, {Matthew R.} and James Waddell and Solimando, {Dominic A.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1310/hpj5008-672",
language = "English (US)",
volume = "50",
pages = "672--677",
journal = "Hospital Pharmacy",
issn = "0018-5787",
publisher = "Facts and Comparisons",
number = "8",

}

TY - JOUR

T1 - Bevacizumab and temozolomide plus radiation regimen for glioblastoma multiforme

AU - Rutledge, Matthew R.

AU - Waddell, James

AU - Solimando, Dominic A.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.

AB - The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases.

UR - http://www.scopus.com/inward/record.url?scp=84975784261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975784261&partnerID=8YFLogxK

U2 - 10.1310/hpj5008-672

DO - 10.1310/hpj5008-672

M3 - Article

VL - 50

SP - 672

EP - 677

JO - Hospital Pharmacy

JF - Hospital Pharmacy

SN - 0018-5787

IS - 8

ER -